000			01634 a2200481 4500
005			20250514041252.0
264		0	_c20020904
008			200209s 0 0 eng d
022			_a1462-0324
024	7		_a10.1093/rheumatology/41.8.876 _2doi
040			_aNLM _beng _cNLM
100	1		_aKarim, M Y
245	0	0	_aMycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. _h[electronic resource]
260			_bRheumatology (Oxford, England) _cAug 2002
300			_a876-82 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAntibodies, Antinuclear _xblood
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aLupus Erythematosus, Systemic _xblood
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMycophenolic Acid _xanalogs & derivatives
650	0	4	_aProteinuria _xprevention & control
650	0	4	_aRacial Groups
650	0	4	_aStatistics, Nonparametric
650	0	4	_aTime Factors
650	0	4	_aTreatment Failure
700	1		_aAlba, P
700	1		_aCuadrado, M-J
700	1		_aAbbs, I C
700	1		_aD'Cruz, D P
700	1		_aKhamashta, M A
700	1		_aHughes, G R V
773	0		_tRheumatology (Oxford, England) _gvol. 41 _gno. 8 _gp. 876-82
856	4	0	_uhttps://doi.org/10.1093/rheumatology/41.8.876 _zAvailable from publisher's website
999			_c12041092 _d12041092